NEERIFY Trademark

Trademark Overview

On Monday, June 7, 2021, a trademark application was filed for NEERIFY with the United States Patent and Trademark Office. The USPTO has given the NEERIFY trademark a serial number of 90759188. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, May 27, 2024. This trademark is owned by Eyenovia, Inc.. The NEERIFY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of ocular diseases and conditions; ophthalmic pharmaceuticals; therapeutic preparations for treatment of presbyopia; eye drops; therapeutic eye spray for treatment of ocular diseases and conditions
neerify

General Information

Serial Number90759188
Word MarkNEERIFY
Filing DateMonday, June 7, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, May 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of ocular diseases and conditions; ophthalmic pharmaceuticals; therapeutic preparations for treatment of presbyopia; eye drops; therapeutic eye spray for treatment of ocular diseases and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 27, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEyenovia, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NameEyenovia, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Wednesday, February 23, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 10, 2021NEW APPLICATION ENTERED
Friday, August 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 23, 2022ASSIGNED TO EXAMINER
Wednesday, February 23, 2022NON-FINAL ACTION WRITTEN
Wednesday, February 23, 2022NON-FINAL ACTION E-MAILED
Tuesday, March 1, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 1, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 9, 2022ASSIGNED TO LIE
Wednesday, March 9, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 15, 2022SOU EXTENSION 1 FILED
Tuesday, November 15, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 15, 2022SOU EXTENSION 1 GRANTED
Thursday, November 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 18, 2023SOU EXTENSION 2 FILED
Thursday, May 18, 2023SOU EXTENSION 2 GRANTED
Tuesday, October 31, 2023SOU EXTENSION 3 FILED
Tuesday, October 31, 2023SOU EXTENSION 3 GRANTED
Thursday, November 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 27, 2024SOU TEAS EXTENSION RECEIVED
Monday, May 27, 2024SOU EXTENSION 4 GRANTED
Monday, May 27, 2024SOU EXTENSION 4 FILED
Tuesday, May 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 31, 2023SOU TEAS EXTENSION RECEIVED
Thursday, May 18, 2023SOU TEAS EXTENSION RECEIVED
Saturday, May 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

neerify treatment therapeutic diseases conditions preparations ocular drops spray presbyopia pharmaceuticals